Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More

BUY Jyothy Laboratories - With multiple triggers, outlook 'bright': Anand Rathi Institutional Research

Posted On: 2016-08-16 20:43:27

Jyothy Laboratories - With multiple triggers, outlook 'bright'; upgrading to a Buy with a target procee of Rs 360

Jyothy Laboratories' Q1 results were ahead of our estimates: 10% volume growth and a strong 370-bp expanded EBITDA margin driving 78% yoy profit growth. The broad-based volume growth and strong operating-margin tailwinds (driven by the gross margin) reflect strengthening business fundamentals. Multiple triggers (a better monsoon driving rural demand pickup, monetisation of its land assets, and Henkel possibly exercising its option to buy a 26% stake) could offer further potential. Hence, we upgrade the stock to a Buy.

A strong Q1 showing. Revenue grew 9% yoy to Rs. 4.4bn (slightly lower than our estimated 11%), aided by 10% volume growth. EBITDA grew 37% yoy to Rs. 791m. The EBITDA margin expanded ~370bps yoy to 18%, primarily driven by lower employee expenses (down 230bps yoy) and a higher gross margin (up 150bps yoy). Adj. PAT grew 78% to Rs. 459m (lower than our Rs. 555m estimate), hit by higher taxes (a 24.6% rate in Q1, vs. no taxes estimated on expectation of amalgamation of the loss-suffering subsidiary).

Margin tailwinds to ensure strong earnings growth. The flagship brand Ujala clocking 10% growth in Q1 reflects that management efforts to drive growth in the mature soap & detergent category are yielding results. Increased brand investments, innovation and distribution initiatives in the non-south market should help sustain the revenue momentum. Further, cost-saving measures, easing input costs and tax benefits should help drive a 47% earnings CAGR over FY16-18.

Valuation. We have tweaked our estimates to reflect taxes in H1 FY17, while factoring in the tax benefits from the amalgamation with the loss-saddled (Rs. 3bn) subsidiary JCM in H2 FY17 and FY18. Thus, we raise our FY18e EPS 16% while reducing the FY17e EPS 13%. We upgrade the stock to a Buy with a revised price target of Rs. 360, based on 27x FY18e vs. Rs. 340 earlier (30x FY18e). Risks: A steep rise in input costs, weaker demand and keener competition in its Home and Personal care sub-segments.

Shares of JYOTHY LABORATORIES LTD. was last trading in BSE at Rs.282.6 as compared to the previous close of Rs. 285.25. The total number of shares traded during the day was 8837 in over 369 trades.

The stock hit an intraday high of Rs. 286.95 and intraday low of 282.6. The net turnover during the day was Rs. 2515275.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Result Update: Time Technoplast Ltd - ACCUMULATE - TP Rs.210 - Kotak
Result Update: PNC Infratech Ltd - ACCUMULATE - TP Rs.154 - Kotak
Result Update: Praj Industries Ltd - REDUCE - TP Rs.73 - Kotak
Result Update: Blue Star Ltd - ACCUMULATE - TP Rs.741 - Kotak
Result Update: AIA Engineering Ltd - SELL - TP Rs.1130 - Kotak
Result Update: KNR Constructions Ltd - ACCUMULATE - TP Rs.236 - Kotak
Result Update: Finolex Industries Ltd - BUY - TP Rs.712 - Kotak
HSIL Q1 FY18 Result Update Rating - HOLD - Arihant Capital Markets
CEO & MD of Infosys Resigns: Angel Broking
Indoco Remedies: 1QFY2018 Result Update - Angel Broking
Aurobindo Pharma: 1QFY2018 Result Update - Angel Broking
Insurance: Widening the base - Kotak
Banks : NIM-short term tailwinds and cyclical headwinds : Deciphering the cause of recent compression of NIM - Kotak
Jagran Prakashan Q1 FY18 Result Update Rating - HOLD - Arihant capital Markets
NCLT admits RCOM merger petition with Aircel: Angel Broking
Views on Sun Pharmaceutical Industries Limited 1QFY2018 Results: Angel Broking
Economy: RBI surplus transfer: real danger of fiscal slippage - Kotak
Views on Cadila Healthcare Ltd 1QFY2018 Results: Angel Broking
Views on Cipla Ltd 1QFY2018 Results: Angel Broking
The Pitch Report - Result Update: Balmer Lawrie Company - BUY - TP Rs.289 - Kotak
The Pitch Report - BBTC - BUY - TP Rs1130 - Kotak
Result Update: NMDC - REDUCE - TP Rs.130 - Kotak
Result Update: Mahanagar Gas Ltd - SELL - TP Rs.1006 - Kotak
Result Update: Tata Motors - BUY - TP Rs.514 - Kotak
Result Update: Gabriel India Ltd - BUY - TP Rs.190 - Kotak
Initiating Coverage: Radico Khaitan Ltd - BUY - TP Rs.200 - Kotak
Views on Indoco Remedies Ltd 1QFY2018 Results: Angel Broking
Bajaj Auto announces a tie-up with Triumph of UK: Angel Broking
Technology 1QFY18 review: Tactical margin levers exercised well - Kotak
Cement - August 4, 2017 - Kotak
Result Update: JSW Steel Ltd - REDUCE - TP Rs.230 - Kotak
Result Update: Carborundum Universal Ltd - SELL - TP Rs.324 - Kotak
Result Update: Container Corporation of India Ltd - REDUCE - TP Rs.1210 - Kotak
HCL Technologies (HCL IN) - Healthy operational performance - CSEC Research
L&T (LT IN) - Strong PAT growth aided by execution in Infra segment - CSEC Research
GlaxoSmithKline Pharmaceuticals - 1QFY2018 Result Update - Angel Broking
Dr. Reddy's Laboratories - 1QFY2018 Result Update - Angel Broking
Views on Lupin Ltd 1QFY2018 Results: Angel Broking
Tech Mahindra - 1QFY2018 Result Update - Angel Broking
Federal Bank - 1QFY2018 Result Update - Angel Broking
Margin expansion on the cards for SBI: Angel Broking
Views on Tech Mahindra Ltd 1QFY2018 Results: Angel Broking
Views on United Phosphorus Ltd 1QFY2018 Results: Angel Broking
Result Update: Blue Dart Express (BDE) - BUY - TP Rs.5150
Result Update: Escorts Ltd - ACCUMULATE - TP Rs.710 - Kotak
Result Update: The India Cements Ltd - BUY - TP Rs.234 - Kotak
Result Update: Larsen & Toubro Ltd - ACCUMULATE - TP Rs.1274 - Kotak
Result Update: NIIT Ltd - ACCUMULATE - TP Rs.110 - Kotak
Maruti Suzuki - 1QFY2018 Result Update - Angel Broking
Federal Bank Q1 FY18 Result Update Rating - HOLD - Arihant Capital Markets


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017